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Abstract
The Regression Discontinuity (RD) design is a quasi-experimental design which
emulates a randomised study by exploiting situations where treatment is assigned
according to a continuous variable as is common in many drug treatment guidelines.
The RD design literature focuses principally on continuous outcomes. In this
paper we exploit the link between the RD design and instrumental variables to obtain
a causal effect estimator, the risk ratio for the treated (RRT), for the RD design when
the outcome is binary.
Occasionally the RRT estimator can give negative lower confindence bounds. In
the Bayesian framework we impose prior constraints that prevent this from happen-
ing. This is novel and cannot be easily reproduced in a frequentist framework.
We compare our estimators to those based on estimating equation and generalized
methods of moments methods. Based on extensive simulations our methods compare
favourably with both methods.
We apply our method on a real example to estimate the effect of statins on
the probability of Low-density Lipoprotein (LDL) cholesterol levels reaching recom-
mended levels.
Keywords: risk ratio for the treated, prior constraints, causal effect
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1 Introduction
The Regression Discontinuity (RD) design is a quasi-experimental design introduced in the
1960’s in Thistlethwaite and Campbell [1960] and widely used in economics and related
social sciences (Imbens and Lemieux [2008]) and more recently in the medical sciences
(Geneletti et al. [2015], Bor et al. [2014]). The RD design enables use of routinely gathered
medical data from general practice (family doctors) to evaluate the causal effects of drugs
prescribed according to well-defined decision rules. Most of the RD design literature focuses
on continuous outcomes. Here we develop Bayesian approach for binary outcomes which
are frequently of primary interest in health care contexts.
The RD design naturally leads to an Instrumental Variable (IV) analysis and so we adapt
the IV based Multiplicative Structural Mean Model (MSMM) Risk Ratio for the Treated
(RTT) estimator (Clarke and Windmeijer [2012, 2010], Hernan and Robins [2006]) to this
context. The RRT is a measure of the change in risk for those who received the treatment.
The MSMM estimator for the RRT is known to occasionally misbehave in that lower 95%
confidence intervals can be negative (Clarke and Windmeijer [2010]). It is possible that this
is why this estimator is not widely used despite its relatively simple formulation and partly
what motivated the widespread use of generalised methods of moment based estimator
(Clarke et al. [2015]). Naive Bayesian estimators of the MSMM RRT also suffer from this
problem; however we circumvent this issue by imposing prior constraints that prevent the
posterior MCMC sample from dropping below zero. This is a novel implementation of prior
constraints and cannot be reproduced in a frequentist framework.
Once the problem of negative values is taken care of, the MSMM RRT estimator turns
out to be very flexible as we can estimate its components using a large number of parametric
and potentially semi-parametric models. While we favour Poisson regression models due
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to theoretical considerations (see Section 2.2) the framework is not limited to this choice
and we give examples of alternatives in the Supplementary materials.
We also compare our estimators to those based on the generalized methods of moments
(Clarke et al. [2015]) amongst others. Based on extensive simulations our methods compare
favourably with the frequentist estimators especially in circumstances that are not ideal.
The paper is organised as follows: In Section 2 we briefly describe the RD design and
introduce our example. Section 2.2 lays out our notation and assumptions. In Section 3 we
describe in detail our models as well as giving a short overview of the competing method
based on the generalized methods of moments. We present the results of a simulation study
in Section 4. Section 5 follows with the results of the real application. We finish with some
discussion in Section 6.
2 Background and example
An analysis based on the RD design is appropriate for public health interventions that are
implemented according to pre-established guidelines proposed by government institutions
such as the Federal Drug Administration (FDA) in the US and the National Institute for
Health and Care Excellence (NICE) in the UK. Specifically, when a decision rule is based on
whether a continuous variable exceeds a certain threshold, it becomes possible to implement
the RD design. In our running example we use data from The Health Improvement Network
a UK data set. We investigate the effect of prescribing statins, a class of cholesterol-lowering
drugs, on reaching the NICE recommended LDL cholesterol targets of below 2 or 3 mmol/L
for healthy and high risk patients respectively. Between 2008 and 2014 NICE guidelines
recommended that statins should be prescribed to patients whose 10 year cardiovascular risk
score exceeded 20% provided they had no history of cardiovascular disease. If we are willing
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to assume that individuals just above and below the 20% threshold are exchangeable – an
essential condition for causal inference in the RD design – then we have a quasi-randomised
trial with those just below the threshold randomised to the no-treatment “arm” and those
just above randomised to the treatment “arm”. Thus any jump or discontinuity in the
values of the outcome across the threshold can be interpreted as a local causal effect or risk
ratio in the case of binary outcomes. For more details see Geneletti et al. [2015].
There are two types of RD designs. The first is termed sharp and refers to the situation
where the guidelines are adhered to strictly. In our application we would encounter a
sharp RD design if all the doctors complied with the NICE guidelines and prescribed
statins exclusively to patients with a 10 year cardio-vascular risk score above 20%. In
practice this is often not the case, and our application makes no exception. There is some
“contamination” whereby individuals who are below the threshold are prescribed statins
while other who are above the threshold receive no prescription. This situation is termed
a fuzzy RD design.
An open question in the RD design literature is how close to the threshold units have to
be in order for the RD design to be valid (Imbens and Kalyanaraman [2012] and Calonico
et al. [2015]). The term bandwidth is typically used to refer to the distance from the
threshold within which the units above and below are used for analysis. In line with
Geneletti et al. [2015] we estimate the RRT for four bandwidths of varying size and assess
sensitivity to these changes.
2.1 Exploratory plots for the RD design
We first present plots (using subsets of the THIN data for the year 2008) that are typically
used to justify the use of the RD design in a fuzzy setting and are useful for understanding
how the RD design works. In all figures the red circles are individuals who do not have
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statin prescriptions while blue x’s represent those who do have statin prescriptions. We
plot the mean of the outcome (continuous or binary) within bins of the risk score (x-axis)
against the risk score and fit a cubic spline. When the splines show jumps at the threshold
this indicates a discontinuity and thus a potential causal effect at the threshold.
The top row of Figure 1 shows a sharp design. On the left, the y-axis is a continuous
measure of LDL cholesterol levels in mmol/L. There is a small but noticeable downward
jump at the threshold. On the right is the corresponding graph of the raw probability of
treatment on the y-axis. Again there is a clear jump from 0 to 1. On the bottom row is
an example of a fuzzy design. This is clear as there are red circles above the threshold and
blue x’s below. Despite the fuzziness there is still a small downward jump at the threshold
as shown in the bottom left hand plot. The bottom right hand plot is the corresponding
raw probability plot. The increase of probability is more gradual but there is a distinct
jump at the threshold (Geneletti et al. [2015]).
Figure 2 shows the plots for the binary outcome LDL cholesterol below 2 mmol/L which
we analyse in Section 5. While there is no discernible jump in the outcome (left), there
is evidence in a jump in the probability of being treated for such patients (right). Taken
together, there is sufficient support for a RD design analysis in this context. The corre-
sponding plots for LDL cholesterol dropping below 3 mmol/l are given in the Supplementary
Material and show a jumps in the outcome and the probability of treatment.
2.2 Assumptions and notation
In order for the RD design to be appropriate a number of formal assumptions also have to
hold. These assumptions are expressed in different ways (Hahn et al. [2001], Imbens and
Lemieux [2008], van der Klaauw [2008], Lee [2008]) and we give a brief overview of them
as described in more detail in Geneletti et al. [2015], Constantinou and O’Keeffe [2015].
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Figure 1: Top row: The sharp design. Bottom row: The real (fuzzy) design. In both cases
means within bins and corresponding fitted cubic spline are overlayed.
In the binary outcome case we need to make additional assumptions in order to identify
the Risk Ratio for the treated our estimator of choice (Didelez et al. [2010], Hernan and
Robins [2006]).
We operate within a decision theoretic framework (Dawid [2002]), as this approach
makes more explicit the assumptions needed to link causal (experimental) and obser-
vational quantities. However the RRT as identified in (2) below and consequently the
Bayesian methods we apply do not rely on this framework and can be interpreted within a
counterfactual or potential outcomes paradigm.
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Figure 2: Mean and probability plots for outcome LDL cholesterol going below 2 mmol/l.
We express our assumptions in the language of conditional independence following
Dawid [1979]. We say that if variable A is independent of another B conditional on a
third C, then p(A,B | C) = p(A | C)p(B | C) and we write A⊥⊥B | C. We refer to our
example to anchor the theoretical arguments. Generalising to other contexts is straightfor-
ward.
Let X be the 10 year cardiovascular risk score. The threshold indicator Z is such that
Z = 1 if X ≥ 0.2 and Z = 0 if X < 0.2. Let T represent statins prescription (not whether
the patient takes the treatment); T = 1 means statins are prescribed and T = 0 means
they are not. Also, let C = {O ∪U} be the set of confounders, where O and U indicate
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fully observed and partially or fully unobserved variables, respectively. Y is the binary
outcome variable where Y = 1 if LDL cholesterol is below 2 (resp, 3) and 0 otherwise.
To reflect the fact that these assumptions are only valid around the threshold, we assume
throughout the paper an additional conditioning on X ∈ [0.2, 0.2+h] if above the threshold
and X ∈ [0.2− h, 0.2] below the threshold for some suitably small h. We do not explicitly
write this conditioning except where necessary.
Finally, in order to be able to use data around the threshold to estimate quantities
with causal meaning we introduce a regime indicator Σ as in (Constantinou and O’Keeffe
[2015]). Σ represents which of the three possible regimes or situations we find ourselves in:
the interventional regime (i.e. the RCT), the sharp RD design or the fuzzy RD design.
Σ =


t, for T = t (= 0, 1), under the interventional regime;
s, for the sharp RD design;
f, for the fuzzy RD design.
When Σ = t we mean that T is set to t with no uncertainty as in an RCT with perfect
compliance. In this case it is akin to the “do” operator (Pearl [2001]) or the intervention
variable F in Dawid [2002]. For clarity we replace conditioning on Σ = ς by a subscript
on the expectation Eς(Y | X,C). It is clear from the definition of Σ that both RD designs
are types of observational data. By defining Σ we can formalise, in terms of conditional
independences, when it is possible to make inference about causal quantities from estimates
based on observational data. We make two further assumptions involving the regime Σ:
A1. (C,X, Z)⊥⊥Σ;
A2. Y⊥⊥Σ | (C,X, Z, T, )
Assumption A1 says that the value of the confounders, the assignment variable (and
trivially the threshold indicator) are marginally independent of the context in which they
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arise, i.e. in an experiment or within and RD design. Under A2, the value of the outcome
does not depend on the regime if we take into account the confounders, the assignment
variable (and trivially the threshold indicator) as well as the prescription status. These
assumptions are termed “sufficiency” assumptions (Dawid and Didelez [2010]) and allow
us to move from the interventional to the RD design regimes.
2.3 RD design assumptions
The first three RD design assumptions are essentially IV assumptions whilst the fourth is
specific to the RD design. See Geneletti et al. [2015] for more details and interpretation.
R1. Association of treatment with threshold indicator : Z 6⊥⊥T | Σ
R2. Independence of guidelines :Z⊥⊥C | (X,Σ),
A weaker version (i.e. within strata of O) is: Z⊥⊥U | (X,O,Σ).
R3. Unconfoundedness : Y⊥⊥Z | (T,C, X,Σ).
R4. Continuity : The expectation of the outcome Eς(Y | X,C, Z, T = t) is continuous at
X = x0 for t ∈ {0, 1} and ς = {s, f}.
2.4 MSMM estimator and associated assumptions
We estimate risk ratios in our analysis as these are of primary interest and most suited to
our method of analysis. In the epidemiological literature odds ratios are usually estimated
as they are easily obtained from logistic regressions. However simple estimators of causal
odds ratios are typically more biased than risk ratio estimators (Didelez et al. [2010]).
9
We focus on estimating the Risk Ratio for the Treated (RRT) defined as follows:
E{E1(Y | Z) | T = 1}
E{E0(Y | Z) | T = 1}
(1)
which is the binary equivalent of the effect of treatment on the treated. This quantity can
be identified in a fuzzy design provided additional assumptions, listed below, are satisfied.
The RRT can be interpreted as ratio of the risk for those who were treated relative to
those who were eligible for treatment. In our example we can think about this as follows:
statins treatment is made available to GP-patient pairs (GPPs) around the threshold thus
all these GPPs are eligible for statin prescription. However, of these only some take up
the treatment. The RRT is a comparison of the outcomes for the patients from GPPs who
prescribed statins relative to all the patients who were eligible and is the binary version of
the effect of treatment on the treated(Geneletti and Dawid [2010]).
The RRT in (1) can be identified from observational RD design data when Y , Z and T
are binary if in addition to R1-R4 the following assumptions hold (Didelez et al. [2010]).
M1: Log-linear in t
log[E1(Y | T = t, Z = z)]− log[E0(Y | T = t, Z = z)] is linear in the treatment.
M2: No T-Z interaction on the multiplicative scale
This assumption is known as the no-effect modification assumption (NEM).
When Assumptions R1-R4 and M1-M2 hold, Σ is defined as in Section 2.2 and conditional
independences A1 and A2 hold, we can use estimators that have been derived in the binary
instrumental variables literature in the context of the RD design without further deriving
any results. Thus we obtain the following formula for the RRT (Hernan and Robins [2006],
Clarke and Windmeijer [2010]):
RRTς = 1−
Eς(Y | Z = 1)−Eς(Y | Z = 0)
Eς(Y T¯ | Z = 1)−Eς(Y T¯ | Z = 0)
, (2)
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where T¯ = (1 − T ) and ς = {s, f}. Equivalent expressions and details of their derivation
and interpretation can be found in Didelez et al. [2010], Abadie [2003], Angrist [2001]. Note
that when Σ = s, (2) reduces to the causal risk ratio. As fuzzy designs are the norm and
sharp the exception we drop the subscript ς for notational clarity, so that implicitly Σ = t.
For the RRT to be above 1, either the numerator or the denominator must be nega-
tive – but not both. In our context we would expect to see a positive numerator as we
would expect there to be more individuals with low cholesterol levels above than below the
threshold. This is because the threshold and the treatment are positively correlated and
treatment reduces cholesterol. The denominator involves the product of Y and ‘no treat-
ment’ T¯ = (1 − T ). As we expect statin treatment to lower cholesterol and be associated
with the threshold indicator, we expect the denominator to be negative. This is reflected in
the results in Section 5, where the RRT is above 1 for both outcomes and most bandwidths
except the smallest for the outcome LDL below 2.
Assumption M2 requires that whether the LDL cholesterol level is below 2 (resp. 3)
does not depend on an interaction term between T (statin prescription) and Z (whether
the risk score exceeds 20% on the log scale). If there were an interaction term it would
mean that the GPs above and below the threshold would be different with respect to their
ability to predict the outcome. This is unlikely to be the case.
The RRT as show in Equation (2) also identifies the local causal risk ratio, the binary
equivalent of the complier average causal effect (Frangakis and Rubin [2002], Imbens and
Angrist [1994]).
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3 Models
The models in Sections 3.2 and 3.3 are embedded in a Bayesian framework. We first obtain
a full posterior MCMC sample for each of the relevant parameters in the models described
in Section 3.2 and combine these to induce a posterior sample for the RRT. When we add
prior constraints in Section 3.3 we sample the RRT directly. From the posterior samples we
easily obtain variances and interval estimates without having to rely on bootstrap methods
or asymptotic arguments, as is the case with the frequentist estimators.
We present a number of possible models to estimate the components. We mostly use the
same types of models in the numerator and the same type in the denominator. However, we
do mix different models in the numerator and denominator where we consider this necessary.
Generally speaking we write the estimates for the RRT as follows: RRTnum.denom where
num indicates the form of the numerator and denom the denominator in the fraction in (2).
3.1 Interaction vs Product models
The denominator of the fraction in the expression for the RRT (henceforth only “the
denominator”) is given by E(Y T¯ | Z = 1) − E(Y T¯ | Z = 0). We can break up the
individual terms further as follows:
E(Y T¯ | Z = z) = E(Y | T¯ , Z)E(T¯ | Z). (3)
In our analysis, we produce estimates for both of these models. We call interaction models
those which use the formulation on the left hand side of equation (3) and product models
those that use the formulation on the right hand side. Our motivation for including analyses
with the product of two conditional probabilities as in (3) is that the data for the product
term are sparse (see Supplementary materials). By using Y alone this is mitigated. We
also consider zero inflated Poisson regression models (Lambert [1992]) to address this but
results are not substantially different.
3.2 Poisson regression models
The first set of models we considered estimates all the components in the RRT using
Poisson regression models, in line with assumption M1. It is easy to verify that if the same
parametric form can be assumed to hold for experimental and observational regimes then
a log-linear relationship in t follows for each of the components of (2).
LetX∗ = X−0.2, we fit Poisson regressions in both the numerator and the denominator:
Numerator :=


yiz ∼ Poisson(µiz)
log(µiz) = αz + βzx
∗
iz
Denominator :=


yt¯iz ∼ Poisson(νiz)
log(νiz) = δz + γzx
∗
iz
with priors αz, βz, δz, γz
iid
∼ Normal(0, 100), iz = 1, . . . , nz and z ∈ {0, 1} throughout.
We put relatively vague priors on the regression coefficients. Tighter priors such as those
suggested in Gelman et al. [2008] have been considered, but results are not very sensitive to
the choice of prior. As we centre the risk score at the threshold, the parameter of interest in
all the regressions is the exponential of the intercept term. The posterior MCMC samples
of the parameters α1, α0, δ1 and δ0 can be used to characterize E(Y | Z = 1), E(Y | Z = 0),
E(Y T¯ | Z = 1), and E(Y T¯ | Z = 0) respectively and then combined to obtain the posterior
sample for the RRT. The model described above has the interaction model denominator:
RRTpois.pois = 1−
Πpois
Ψpois
where
Πpois = exp(α1)− exp(α0) and Ψpois = exp(δ1)− exp(δ0)
We also consider an interaction model where the denominator is based on a flexible Binomial
model as used in Geneletti et al. [2015]. In this model the prior information is used to
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create distance between the two elements in the denominator of the fraction in the RRT
in (2). This often stabilises the results because it pushes the difference in the probability
of treatment at the threshold away from zero and thus inflates the fraction in (2). In this
case the denominator is defined as
Denominator: yt¯iz ∼ Binomial(qz, nz)
priors: logit(q1) ∼ Normal(−3, 1) and logit(q0) ∼ Normal(3, 1) so Ψflex = q1 − q0.
This results in the interaction model
RRTpois.flex = 1−
Πpois
Ψflex
.
We now consider the product denominator as follows:
Denominator.prod =


yiz ∼ Poisson(θiz)
log(θiz) = δz + γzxiz + κz t¯iz
tiz ∼ Binomial(rz, nz)
priors: logit(r1) ∼ Normal(−3, 1) and logit(r0) ∼ Normal(3, 1).
We then combine the conditional probabilities as follows
E(Y T¯ | Z = z) = (δz + κz)× rz,
as we are interested in the case where both Y and T¯ are equal to 1. Note that we use the
Binomial flex model again for the probability of T¯ as this was less variable than regression-
based models, in this case. Thus we obtain RRTpois.prod.flex as follows:
RRTpois.prod.flex = 1−
Πpois
Ψprod.flex
where Ψprod.flex = exp(δ1 + κ1)r1 − exp(δ0 + κ0)r0.
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3.3 Constraints
The RRT can drop below zero if the fraction in (2) exceeds one (Clarke and Windmeijer
[2010]). We avoid the problem by imposing a priori constraints on the distribution of the
RRT which force the RRT to remain within the acceptable bounds.
Imposing prior constraints is easy in the Bayesian framework. We put a Gamma prior
on the RRT with most of the mass close to 1, as we do not want to encourage a large
risk ratio. The most straightforward constraint was to make α1 a function of the other
variables above the threshold so that we could place a prior on the RRT. We could equally
have chosen α0. We write out the changes the model implies to the priors below:
RRTpois.pois ∼ Gamma(3, 1) and α1 = log{(1− RRTpois.pois)Ψpois + exp(α0)}
where exp(α1)− exp(α0) = Πpois and there is of course no prior on α1. Similar changes can
be made to all the RRTs with any of the other models presented in Section 3. It is also
possible to impose constraints on logistic regression based estimates.
3.4 Generalized Method of Moments analysis
In order to assess the performance of our Bayesian estimators, we compared them to some
of the most common estimators for binary outcomes in the IV literature. These include
the Generalized Method of Moments (GMM) MSMM estimator (Clarke et al. [2015]), the
Wald Risk Ratio (Didelez et al. [2010]) and a final method based on a single estimating
equation (Burgess et al. [2014]). We give a brief overview and show results in Table 1 of
Section 5 for the first of these methods as it outpeformed the other two. Details and results
for the other methods can be found in the Supplementary material.
Clarke et al. [2015] showed that the semi-parametric MSMM estimator in equation (2)
can be estimated efficiently by the Generalized Method of Moments (GMM). The moment
15
conditions
E

 Y exp(−β0X)− α0
{Y exp(−β0X)− α0}Z

 =

 0
0


lead to the estimation of α0 and β0 by the method of moments.
4 Simulation study
We set up a simple simulation study aimed at examining the properties of the models
presented in Section 3 under two levels of unobserved confounding (U), two levels of IV
strength (Z) and three causal effects. Thus we performed simulations for 12 Scenarios.
We based our simulated data set on the larger data set from which the one described in
Section 2 and analysed in Section 5 was obtained. Thus we used the original values for
the risk score X and the standardized HDL cholesterol level as unobserved confounder U .
The threshold indicator Z was defined deterministically as Zi = 0 if Xi < 0.2 and Zi = 1
otherwise. For each simulation and in the real data in Section 5 we run the analyses in
each of four bandwidths identified by values h = {0.025, 0.05, 0.075, 0.1} and assess the
sensitivity of the results to these changes.
We generate assigned treatment and outcome in order to get different settings of
strength of instrument (Weak or Strong), unobserved confounding (Low or High) and three
different risk ratios: 1, 2.11 and 4.48 corresponding to no, low and high causal effect. More
details about the simulation mechanism are in the Supplementary material.
We produced exploratory plots like those introduced in Section 2 for all the simulated
scenarios. Briefly, for high causal effects all scenarios showed a clear jump at the threshold
although it was smaller in the weak IV high confounding scenario. For the low causal effects
results were variable. No jump was discernible in the weak IV high confounding scenario
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but a clear jump was visible in the strong IV scenarios. Finally for the no-effect scenarios
no jump was visible as expected. A selection of plots can be seen in the Supplementary
Materials.
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Figure 3: Comparison of the results in 4 out of 12 simulated scenarios.
We obtained results for Bayesian constrained and unconstrained models as well as a
number of frequentist estimates and the Balke-Pearl bounds which are available on website
xxx In the body of the paper we only present results for the constrained models as in many
scenarios (in particular for small bandwidths, high confounding and weak instruments) the
posterior MCMC sample for the unconstrained models contained values below zero. In
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addition, while convergence was reached for the relevant parameters, there were some ex-
treme results due to small values in the denominator that occasionally led to inflated mean
estimates. Medians for the unconstrained models and means for the constrained models
were generally close although the constrained model estimates were typically smaller. We
thought this might be due to the Gamma prior pulling the RRT in the constrained models
towards one. However upon investigation we saw that results were not sensitive to the
choice of prior.
Figure 3 shows the results for 3 estimators in 4 out of 12 simulated scenarios (full results
for all simulated scenarios are available on request). We selected pois.flex (in red) and
pois.prod.flex (blue). Also we plot the MSMM estimator obtained using GMM (orange).
For each estimator, a solid coloured line represents the 95% confidence or credible interval
while the dot represents the mean value. The true risk ratio is shown using a solid horizontal
black line, and in case the true effect differs from 1, a dotted line indicates the absence of
effect.
In panel A the risk ratio is 4.48. Here the Bayesian model outperforms the others. The
mean RRT is closer to the true value and the intervals are considerably narrower, especially
when small bandwidths are considered.
In panels B and C the true risk ratio is equal to 2.11 and the estimators show mixed
behaviour. Results in B are relative to the worst possible scenario, where confounding is
high and the instrument is weak. All estimators underestimate the real effect and all 95%
intervals include 1. Bayesian Point estimates are less biased and their intervals always
include the true value. This is not the case for GMM whose intervals do not include 2.11
for most bandwidths.
Results in C are for the low confounding-weak instrument scenario. Bayesian estimators
show similar behaviour for all values of h, overestimating the true value, but including it
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within the 95% interval. The GMM based method gives wider and misleading intervals
which include the value 1 in the smaller bandwidths h ∈ {0.025, 0.05}.
Finally panel D represents the scenario with high level of confounding, weak instrument
and no effect. With h > 0.025 the GMM estimator perform better in terms of both point
and interval estimation however it is very sensitive to the sample size. In h = 0.025 the
intervals are very wide. The Bayesian estimates result in very high point estimates but
their intervals include 1.
Overall the Bayesian estimators appear to be more robust to IV strength, confounding
levels and size of causal effect. For small bandwidths none of the methods performs partic-
ularly well when the risk ratio is small or one, however the Bayesian estimator compares
favourably with the competing methods in the borderline cases. A possible reason for the
robustness of Bayesian estimators in the extreme scenarios is that continuous information is
used in estimating the components of the RDD whereas the GMM (and other frequentist)
estimates are based on binary data only.
5 Example: Statin prescription
5.1 Data
The data we consider are a subset of The Health Improvement Network (THIN) data set.
THIN are primary care data for over 500 practices in the UK and include a large number of
individual patient, diagnostic and prescription information. We focus on a subset of 1386
male patients between 50 and 70 who did not smoke or have diabetes in the year 2008. We
investigate whether statin prescription lowers the LDL cholesterol to below two and three
mmol/L, recommended levels for high and low risk individuals respectively.
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From trials (Ward et al. [2007]) we know that statins are effective in lowering cholesterol.
As LDL cholesterol tends to decrease quickly within a month of uptake and our data span
the 6 months around the cholesterol measurement we can use our binary outcomes RD
design to determine whether statins result in people achieving LDL cholesterol targets
within a small time window. Our approach is also useful when we are interested in whether
a drug acts on a relevant marker of a disease which is easier to measure and is affected
quickly by treatment.
5.2 Preliminary analyses
Prior to estimating the RRT we investigated whether a Poisson regression was an appro-
priate models for the data. Model fit was good overall and there was no evidence for
overdispersion.
In line with recent recommendations regarding what should be presented in IV analyses
(Swanson and Hernan [2013]) we performed F-tests to determine IV weakness for non-linear
situations (Windmeijer and Didelez [2016]) for both binary outcomes (LDL below 2 and
below 3). The F-values ranged from 10 (for bandwidth 0.025) to 211 (for bandwidth 0.1)
with p-values significant at the 5% level throughout. The Balke-Pearl bounds Balke and
Pearl [1997], Palmer et al. [2011] were also in line with our results.
5.3 Main analysis
We fitted our models using JAGS (Plummer [2003]) with two chains, a burn-in of 10,000
iterations and a further 50,000 iterations. Our posterior samples were based on the last
1000 iterations. On average each estimator took 5 minutes to run on a standard PC.
Convergence was reached for all relevant parameters.
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All, LDL< 3 All, LDL< 2
Mean L95 U95 Mean L95 U95
h = 0.025
pois.flex 3.12 1.32 5.62 2.59 0.86 5.57
pois.pois 3.98 1.32 8.16 2.96 0.89 6.42
pois.prod.flex 3.89 1.11 6.16 2.77 0.77 5.81
GMM 3.99 1.30 12.21 8.39 1.49 47.37
h = 0.05
pois.flex 3.95 1.51 7.39 2.59 0.99 4.91
pois.pois 4.01 1.12 7.93 2.81 0.85 5.92
pois.prod.flex 4.17 1.08 8.14 2.64 0.85 5.34
GMM 4.53 2.29 8.93 4.49 3.04 29.62
h = 0.075
pois.flex 3.76 1.48 7.84 2.63 1.02 4.76
pois.pois 4.33 1.47 8.60 3.19 0.95 6.13
pois.prod.flex 4.60 1.57 8.60 2.80 1.01 5.33
GMM 4.22 2.55 7.03 6.68 3.07 14.56
h = 0.1
pois.flex 3.69 1.42 6.82 4.20 1.02 7.13
pois.pois 4.02 1.37 7.60 6.82 1.25 4.50
pois.prod.flex 3.99 1.36 7.36 2.70 1.31 4.86
GMM 3.76 2.60 5.44 7.36 3.73 14.55
Table 1: The table contains the results for estimates of the constrained RRT as well as the
GMM based estimator.
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Overall the results indicate a positive effect of statin treatment on LDL cholesterol
levels for patients in our sample with a large (if not universally significant) two to three-
fold increase in the probability of achieving the target LDL cholesterol level within 6 months
of prescription for those prescribed relative to those eligible. This is especially true for the
target of reducing the LDL cholesterol level to below 3 mmol/L.
Table (1) shows for each bandwidth the mean, upper and lower 95% interval estimates
for the RRT with constrained models and the GMM. The plots in Figure 4 show the RRT
estimates for the unconstrained models in the left and the constrained models in the right
for LDL below 3. We can see that in particular for the low bandwidths where the data
are sparse the estimates using the unconstrained models are very variable. Similar plots
displaying a similar pattern for the LDL below 2 are given in the Supplementary Materials.
Overall the constrained estimates both reduce the variability of the estimates and ensure
that they remain above zero.
Generally, Bayesian estimates are similar and increase slightly as the bandwidth in-
creases. The estimates for LDL<3 mmol/L are slightly larger than those for LDL< 2 and
always significant. If you consider that the median LDL cholesterol for the untreated is
approximately 4 then it is easy to see that to reduce the level to below 2 when statins are
thought to reduce cholesterol by up to 2mmol/L is going to be difficult. Thus it makes
sense that for LDL<2 mmol/L the RRT is not significant for small bandwidths.
When we compare the results of the GMM methods to ours we see that for the LDL
below 3 scenarios are broadly similar. For the outcome LDL below 2 however results are
different. For all the bandwidths the means of the GMM are very high and the intervals
are wide. Also, from our simulation studies – which are based on the same data – we know
that for small bandwidths (i.e. small sample sizes) the GMM estimators over-estimate the
effects and are less robust in general than the Bayesian estimates.
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Figure 4: On the left and right are the means and 95% credible intervals when the models
are unconstrained and constrained respectively. The y-axis have different scales.
6 Conclusions
In this paper we use the RD design to develop a Bayesian method to estimate the risk ratio
for the treated (Hernan and Robins [2006], Clarke and Windmeijer [2010]) which does not
stray below zero. We do this by imposing prior constraints. As this represents a very strong
assumption, we assessed how much results were affected. Counter to our expectation results
from our simulations and applied example constraining the models to be above zero did
not result in higher RRT estimates, nor were results very sensitive to prior specification.
Specifically varying the values of the Gamma distribution on the RRT (e.g., by moving
the mass further from 1) or even using a different prior with positive support (i.e., the
log-normal) did not alter results substantially. Instead the constrained models stabilised
the posterior MCMC sample.
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The fact that the RTT as identified by (2) has no built-in safe guard to dropping below
zero raises some questions as to its appropriateness as a risk ratio estimator. It is not easy
to identify causal quantities when all elements are binary and as a consequence a number of
strong assumptions must be met. It is likely that some will hold only approximately. If we
suspect that assumptions R1-R4 do not hold then there is no point in attempting an RD
analysis or estimating the RRT from these data; however if we think of M1-M2 as holding
only approximately around the threshold then we can view this as a model misspecification
problem and the RRT as an approximation to the true underlying effect.
Our results compared favourably to those of the generalised method of moments as well
and other frequenstist estimators. In particular they were more robust to weak instruments,
high levels of confounding and low effects in the simulation studies. They also produced
more credible results in our application.
A further advantage of our approach is that as we model the individual components of
the RRT jointly (possibly subject to constraints) we can be very flexible in our choice of
models. We propose Poisson regression based models on theoretical grounds and because
in the RD design we can exploit the continuous information in the risk score. However
Poisson regressions do not guarantee that the coefficients or predictions of the regression
behave like probabilities. While our results do not misbehave in this way it is something to
bear in mind. Due to the flexible approach we have developled we also have implemented
models identical to those we propose where logs are replaced by logits and exponentials
with expits. Futher we have tried zero-inflated Poisson regression models and Binomial
models. Results are broadly similar especially for the regression based models. JAGS code
for some of these models is given in the Supplementary materials and results are available
on request. It is also feasible to use splines or other semi-parametric models.
There are also a number of papers that focus on estimating causal odds ratios, notably
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Vansteelandt et al. [2011], Vansteelandt and Goetghebeur [2003], van der Laan et al. [2007].
While we have not done this here it should be possible to use the double logistic causal odds
ratio estimator in a way similar to how we use the MSMM risk ratio estimator although
additional requirements (e.g. specifying a model for P (Y | T, Z)) need to be taken into
account.
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